2017 annual financial data
Summit Therapeutics 2017 Operating margin
Summit Therapeutics 2017 operating margin with verified reported values.
Direct answer
Operating margin was -182.31%.
Operating income was -25,829,000 GBP and net income was -20,158,000 GBP.
Operating cash flow was -20,580,908 GBP.
Get free Summit Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 14,168,000 GBP
- Operating income
- -25,829,000 GBP
- Net income
- -20,158,000 GBP
- Operating cash flow
- -20,580,908 GBP